These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 25714506

  • 1. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH, Ming WK, Chan PK.
    Hum Vaccin Immunother; 2015; 11(3):564-71. PubMed ID: 25714506
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
    You JH, Ming WK, Chan PK.
    BMC Infect Dis; 2014 Nov 25; 14():618. PubMed ID: 25420713
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
    García A, Ortiz de Lejarazu R, Reina J, Callejo D, Cuervo J, Morano Larragueta R.
    Hum Vaccin Immunother; 2016 Sep 25; 12(9):2269-77. PubMed ID: 27184622
    [Abstract] [Full Text] [Related]

  • 5. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ.
    Value Health; 2016 Dec 25; 19(8):964-975. PubMed ID: 27987647
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Jiang M, Li P, Wang W, Zhao M, Atif N, Zhu S, Fang Y.
    Vaccine; 2020 Jan 29; 38(5):1057-1064. PubMed ID: 31787414
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.
    BMC Infect Dis; 2015 Oct 27; 15():465. PubMed ID: 26503131
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G, Gregg M, Poulsen Nautrup B.
    J Med Econ; 2015 Oct 27; 18(9):746-61. PubMed ID: 25903831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
    Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M.
    BMC Public Health; 2016 Jul 22; 16():630. PubMed ID: 27449665
    [Abstract] [Full Text] [Related]

  • 14. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
    Crépey P, Boiron L, Araujo RR, Lopez JG, Petitjean A, de Albuquerque Luna EJ.
    BMC Public Health; 2020 Sep 09; 20(1):1374. PubMed ID: 32907562
    [Abstract] [Full Text] [Related]

  • 15. [Cost-effectiveness analysis of quadrivalent influenza vaccination for older adults aged 60 and above in mainland China].
    Yan H, Yang J, Chen ZY, Gong H, Zhong GJ, Yu HJ.
    Zhonghua Yi Xue Za Zhi; 2021 Aug 10; 101(30):2405-2412. PubMed ID: 34404135
    [Abstract] [Full Text] [Related]

  • 16. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
    Zeevat F, Crépey P, Dolk FCK, Postma AJ, Breeveld-Dwarkasing VNA, Postma MJ.
    Value Health; 2021 Jan 10; 24(1):3-10. PubMed ID: 33431150
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.